Mitapivat
AG348-C-025
Approved small_molecule active
Quick answer
Mitapivat for Pyruvate Kinase Deficiency is a Approved program (small_molecule) at AGIOS PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- AGIOS PHARMACEUTICALS, INC.
- Indication
- Pyruvate Kinase Deficiency
- Phase
- Approved
- Modality
- small_molecule
- Status
- active